Case studies


Pharmaceutical and medical device carbon footprint studies will be uploaded soon.

Care Pathways

Type 2 Diabetes Management

Novo Nordisk has completed an innovative study identifying the greenhouse gas (GHG) emissions associated with management of type 2 diabetes.  Good and poor adherence management scenarios were considered, weighing up the additional requirements for good management against the additional complications that arise from poor management.  The results show that the GHG emissions for the well managed scenario are lower across the life time of the patient.

If you have a case study that you would like to share please contact SDU - or 0113 825 3220.